{"schema_version":"secwatch.filing_event.v1","accession":"0001510964-23-000030","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.147900+00:00","generated_at":"2026-06-11T10:54:32.731389+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CV Sciences Q2 revenue $4.0M; gross margin 43.3%, operating loss narrows to $1.1M","bullets":["Revenue of $4.0M, down 4% YoY from $4.1M; units sold down 16%, offset by higher average selling price.","Gross margin improved to 43.3% vs 30.7% YoY; operating loss narrowed to $1.1M from $2.3M.","Cash balance $1.7M at quarter-end vs $0.6M at FY2022; generated $2.4M cash from operations in H1 2023 (incl. $2.5M ERC).","Extinguished outstanding note payable; evaluating strategic options including merger or sale.","Maintained #1 hemp extract brand in natural product retail channel; launched PlusCBD Reserve Collection Extra Gummies."],"urls":{"canonical":"https://secwatch.observer/filing/0001510964-23-000030","json":"https://secwatch.observer/filing/0001510964-23-000030.json","markdown":"https://secwatch.observer/filing/0001510964-23-000030.md","text":"https://secwatch.observer/filing/0001510964-23-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/0001510964-23-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/cvsi-20230814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T10:54:32.731389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d6f6d8438c90428340c5b749a538162c44456f9","claim":"CV Sciences, Inc. reported the quarter ended June 30, 2023 results: revenue $4.0 million.","evidence_excerpt":"and products, today announced its financial results for the quarter ended June 30, 2023. Second Quarter 2023 and Recent Financial and Operating Highlights • Generated revenue of $4.0 million for the second quarter 2023 compared to $4.1 million for second quarter 2022; • Recognized gross margin of 43.3% for the second quarter 2023 compared to 30.7% for the second","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/0001510964-23-000030-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$4.0 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}